Bismacine

Last updated May 30, 2025

Bismacine, also known as Chromacine, is a substance manufactured by American Biologics Corporation and marketed as a purported alternative treatment for Lyme disease. Bismacine is based on bismuth compounds, and two deaths have followed the use of intravenous bismacine to treat Lyme disease.^[1] In 2006, the U.S. Food and Drug Administration warned consumers not to use bismacine, noting that it is ineffective and dangerous.^[2]

References

↑ Quirk M. (2006). "Alternative health therapy for Lyme disease results in death". Lancet Infect Dis. 6 (8): 546. doi:10.1016/S1473-3099(06)70563-1.
↑ "FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine". U.S. Food and Drug Administration. 2006-06-21. Archived from the original on June 25, 2009. Retrieved 2008-10-16.

This article about alternative medicine is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[1] Quirk M. (2006). "Alternative health therapy for Lyme disease results in death". Lancet Infect Dis. 6 (8): 546. doi:10.1016/S1473-3099(06)70563-1.

[fda-2] "FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine". U.S. Food and Drug Administration. 2006-06-21. Archived from the original on June 25, 2009. Retrieved 2008-10-16.

[1]

[2]